Kriti Nutrients AGM: All resolutions passed, including financial statements, dividend, and key appointments.
Kriti Nutrients Limited held its 30th AGM on August 12, 2026. All resolutions passed, including adoption of FY26 financial statements and confirmation of interim dividend for FY26. Mr. Saurabh Singh Mehta re-appointed as Director and Joint Managing Director. Mr. Shiv Singh Mehta re-appointed as Chairman and MD. M/s Mehta & Company re-appointed as statutory auditors.
The passing of resolutions related to financial statements, dividend, and key management appointments is crucial for the company's governance and operational continuity. The re-appointment of auditors also ensures compliance.
All resolutions, including financial statements, dividend, director appointments, and auditor re-appointment, were passed unanimously or with a significant majority, indicating shareholder confidence and smooth governance.
Kriti Nutrients Limited announced the results of the 30th Annual General Meeting (AGM) held on August 12, 2026, through Video Conferencing. The Chairman declared the results of remote e-voting and e-voting conducted during the AGM on August 14, 2026.
All resolutions presented at the AGM were passed with the requisite majority. These included the adoption of the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the confirmation of the interim dividend payment for the financial year 2025-26.
Furthermore, the shareholders approved the re-appointment of Mr. Saurabh Singh Mehta as a director and his revised remuneration, along with his designation as Joint Managing Director. The re-appointment and fixation of remuneration for Mr. Shiv Singh Mehta as Chairman and Managing Director were also approved. Additionally, M/s Mehta & Company, Chartered Accountants, were re-appointed as the statutory auditors, and the remuneration of the cost auditor for FY 2026-27 was ratified.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.